Coreg and Retrovir drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Coreg (carvedilol) and Retrovir (zidovudine). Common drug interactions include back pain among females and anxiety among males.
The phase IV clinical study analyzes what interactions people have when they take Coreg and Retrovir. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.
What is Coreg?
Coreg has active ingredients of carvedilol. It is often used in high blood pressure. eHealthMe is studying from 49,583 Coreg users. Check the latest studies of Coreg.
What is Retrovir?
Retrovir has active ingredients of zidovudine. eHealthMe is studying from 8,751 Retrovir users. Check the latest studies of Retrovir.
30 people who take Coreg and Retrovir together, and have interactions are studied.

What are the common drug interactions of Coreg and Retrovir, by gender? *:
female:
- Back pain
- Bacterial infection
- Blood triglycerides increased
- Bone density decreased
- Bone infarction (ischemic death of the cellular elements of the bone and marrow)
- Bone lesion (bone with abnormalities. bone lesions can result from growth formations, infections, or injuries)
- Bursitis (inflammation of a bursa, typically one in the knee, elbow, or shoulder)
- Cardiac failure congestive
- Cerebral atrophy (decrement in size of brain)
- Cerumen impaction
male:
- Anxiety
- Chronic kidney disease
- Cough
- Hypoaesthesia (reduced sense of touch or sensation)
- Muscle spasms (muscle contraction)
- Musculoskeletal chest pain (pain in chest muscle or nerve or bones)
- Nausea (feeling of having an urge to vomit)
- Osteopenia (a condition where bone mineral density is lower than normal)
- Palpitations (feelings or sensations that your heart is pounding or racing)
- Spinal osteoarthritis (joint cartilage loss in spine)
What are the common drug interactions of Coreg and Retrovir, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Chronic kidney disease
- Emotional distress
- Fatigue (feeling of tiredness)
- Pain
- Renal disorder (kidney disease)
- Renal failure (kidney dysfunction)
- Spinal osteoarthritis (joint cartilage loss in spine)
40-49:
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Depression
- Emotional distress
- Pain
- Asthenia (weakness)
- Chronic kidney disease
- Fatigue (feeling of tiredness)
- Anaemia of chronic disease
- Apathy
50-59:
- Chronic kidney disease
- Emotional distress
- Pain
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Renal failure (kidney dysfunction)
- Multiple injuries
- Nephropathy (damage to or disease of a kidney)
- Asthenia (weakness)
- Depressed mood
60+:
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Renal failure (kidney dysfunction)
- White blood cell count decreased
- Anaemia (lack of blood)
- Asthenia (weakness)
- Blood pressure decreased
- Diarrhoea
- Dyspnoea (difficult or laboured respiration)
- General physical health deterioration (weak health status)
What are the existing conditions these people have? *
- Hiv Infection: 16 people, 53.33%
- Hyperlipidaemia (presence of excess lipids in the blood): 5 people, 16.67%
- Infection: 4 people, 13.33%
- Erection Problems: 3 people, 10.00%
- Diarrhea: 2 people, 6.67%
- High Blood Cholesterol: 2 people, 6.67%
- Headache (pain in head): 2 people, 6.67%
- Haemolytic Anaemia (anaemia due to haemolysis): 2 people, 6.67%
- Drowsiness: 2 people, 6.67%
- Wheezing (a high-pitched whistling sound made while you breath): 2 people, 6.67%
* Approximation only. Some reports may have incomplete information.
Do you take Coreg and Retrovir?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Coreg and Retrovir:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Coreg:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Retrovir:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Coreg and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Retrovir and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Barold, S. S., & Upton, S. , "Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol", Case reports in cardiology, 2018 Jan .
- Kim MS, Baek IH, "Effect of dronedarone on the pharmacokinetics of carvedilol following oral administration to rats", European Journal of Pharmaceutical Sciences, 2018 Jan .
- Barold, S. S., & Upton, S. , "Hyperkalemia Induced by the Sequential Administration of Metoprolol and Carvedilol", Case reports in cardiology, 2018 Jan .
- Kim MS, Baek IH, "Effect of dronedarone on the pharmacokinetics of carvedilol following oral administration to rats", European Journal of Pharmaceutical Sciences, 2018 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on carvedilol and zidovudine (the active ingredients of Coreg and Retrovir, respectively), and Coreg and Retrovir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Aptyalism and Rashes - now
- Could Ergocalciferol cause Thyroiditis? - a second ago
- Drug interactions of Duragesic-100 and Flumadine - 7 seconds ago
- Could Zylet cause Itching? - 8 seconds ago
- Drug interactions of Fluvastatin and Aranesp - 9 seconds ago
- Could Azithromycin cause Urinary Incontinence Aggravated? - 13 seconds ago
- Could Insulin cause Proteinuria Present? - 17 seconds ago
- Could Bilberry cause Rashes? - 18 seconds ago
- Could Azithromycin cause Opportunistic Infection? - 22 seconds ago
- Could Prednisolone cause Catheter Site Pain? - 24 seconds ago